Biblio
Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer. Mol Cancer. 2024;23(1):3.
. CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer. Mol Cancer. 2023;22(1):6.
. Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism. NPJ Biofilms Microbiomes. 2023;9(1):29.
.